Aripiprazole
Aripiprazole is a generic atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and other mental health conditions. Manufactured by Aurobindo Pharma Limited, it's available as oral tablets in strengths of 2mg, 5mg, 10mg, 15mg, 20mg, and 30mg. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Aripiprazole is a generic atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, and other mental health conditions. Manufactured by Aurobindo Pharma Limited, it's available as oral tablets in strengths of 2mg, 5mg, 10mg, 15mg, 20mg, and 30mg. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Aripiprazole",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Aripiprazole — ANDA 202101 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202101"
}
]
|
| identifier | ANDA202101 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-safety",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Aripiprazole |
